Each week we highlight five things affecting the life sciences industry. Here's the latest. Addressing clinical trials challenges in biopharma ecosystem Experts at the Outsourcing in Clinical Trials Conference in New England discussed strategies for navigating the challenging biopharma ecosystem, ... READ MORE >
Life sciences
5 things to know in life sciences: Week of November 4, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. How the election might affect the life sciences industry Fierce Pharma provides some initial thoughts regarding the impact of Donald Trump’s election. Issues considered include changes to the Inflation ... READ MORE >
5 things to know in life sciences: Week of October 28, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. UK Parliament considering new post-market surveillance regulations The UK government has introduced new regulations for post-market surveillance of medical devices, aiming to enhance patient safety and device ... READ MORE >
Medtech executives discuss regulatory collaboration, AI, strategic funding and more
What’s on the minds of the world’s top medtech executives? I recently attended AdvaMed’s medtech conference in Toronto to explore that question. The following includes some key takeaways from the event. Governmental agencies and medtech sector demonstrate a positive working relationship As someone who ... READ MORE >
5 things to know in life sciences: Week of October 21, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. New antibody discovery software unveiled Dotmatics, a research and development software provider, is launching a platform for therapeutic antibody discovery that integrates sequence visualization, antibody ... READ MORE >
5 things to know in life sciences: Week of October 14, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. German company announces positive results for a celiac disease trial Topas Therapeutics, a German biotech company, reported positive phase 2a results for its celiac disease candidate, showing a good safety ... READ MORE >
5 things to know in life sciences: Week of October 7, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. FDA approves at-home COVID/flu combo test for fall season The U.S. Food and Drug Administration has approved an at-home test by Healgen that detects both COVID-19 and influenza A and B, marking a significant ... READ MORE >
5 things to know in life sciences: Week of September 30, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Positive outlook for CDMOs heading into 2025 Despite challenges in the biopharma contracting sector following the COVID-19 boom, 49% of contract development and manufacturing organizations remain ... READ MORE >
5 things to know in life sciences: Week of September 23, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Federal government prolongs reimbursement cuts for lab services Congress has delayed Medicare reimbursement cuts for lab services by passing a short-term funding bill, postponing the implementation of new ... READ MORE >
5 things to know in life sciences: Week of September 16, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. New Alzheimer’s drug shows promise in early trials In patients with Alzheimer's disease, astrocytes can either help break down harmful amyloid beta plaques or worsen the condition by secreting amyloid beta ... READ MORE >